These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17692175)

  • 1. Point: the value of predicting life expectancy in men with clinically localized prostate cancer.
    Clayton DB; Urban DA
    J Natl Compr Canc Netw; 2007 Aug; 5(7):703-8. PubMed ID: 17692175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.
    Sammon JD; Abdollah F; D'Amico A; Gettman M; Haese A; Suardi N; Vickers A; Trinh QD
    Eur Urol; 2015 Nov; 68(5):756-65. PubMed ID: 25819724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.
    Sohlberg EM; Thomas IC; Yang J; Kapphahn K; Daskivich TJ; Skolarus TA; Shelton JB; Makarov DV; Bergman J; Bang CK; Goldstein MK; Wagner TH; Brooks JD; Desai M; Leppert JT
    Urol Oncol; 2020 Sep; 38(9):734.e1-734.e10. PubMed ID: 32674954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
    J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Competitive morbidity ant its impact on life expectancy: evaluation and inclusion in the therapeutic decision regarding localized prostatic cancer].
    Soulié M; Villers A; Richaud P; Prapotnich D; Ruffion A; Grosclaude P
    Prog Urol; 2001 Dec; 11(6):1195-204. PubMed ID: 11859652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic literature review of life expectancy prediction tools for patients with localized prostate cancer.
    Kent M; Vickers AJ
    J Urol; 2015 Jun; 193(6):1938-42. PubMed ID: 25463998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting life expectancy in men with clinically localized prostate cancer.
    Cowen ME; Halasyamani LK; Kattan MW
    J Urol; 2006 Jan; 175(1):99-103. PubMed ID: 16406881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Localized prostatic cancer. Survival and loss of life expectancy].
    Brasso K; Friis S; Juel K; Jørgensen T; Iversen P
    Ugeskr Laeger; 1998 Jul; 160(31):4517-20. PubMed ID: 9700306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counterpoint: prostate cancer life expectancy can not be accurately predicted from currently available tools.
    McCloskey SA; Kuettel MR
    J Natl Compr Canc Netw; 2007 Aug; 5(7):709-13. PubMed ID: 17692176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of the National Comprehensive Cancer Network
    Daskivich TJ; Wood LN; Skarecky D; Ahlering T; Freedland S
    J Urol; 2017 Feb; 197(2):356-362. PubMed ID: 27582436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting life expectancy in prostate cancer patients.
    Jeldres C; Latouff JB; Saad F
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):166-9. PubMed ID: 19553817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calculating life expectancy to inform prostate cancer screening and treatment decisions.
    Hawken SR; Auffenberg GB; Miller DC; Lane BR; Cher ML; Abdollah F; Cho H; Ghani KR;
    BJU Int; 2017 Jul; 120(1):9-11. PubMed ID: 28199761
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival among men with conservatively treated localized prostate cancer.
    Albertsen PC; Fryback DG; Storer BE; Kolon TF; Fine J
    JAMA; 1995 Aug 23-30; 274(8):626-31. PubMed ID: 7637143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign.
    Friedlander DF; von Landenberg N; Löppenberg B; Noldus J; Lipsitz SR; Cole AP; Abdollah F; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    J Urol; 2019 Apr; 201(4):728-734. PubMed ID: 30633112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
    Black A; Berg CD
    Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The implications of ageing and life expectancy in prostate cancer treatment.
    Kalra S; Basourakos S; Abouassi A; Achim M; Volk RJ; Hoffman KE; Davis JW; Kim J
    Nat Rev Urol; 2016 May; 13(5):289-95. PubMed ID: 27001016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful external validation of a model to predict other cause mortality in localized prostate cancer.
    Kent M; Penson DF; Albertsen PC; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Ehdaie B; Scardino PT; Vickers AJ
    BMC Med; 2016 Feb; 14():25. PubMed ID: 26860993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of watchful waiting for clinically localized prostate cancer.
    Steinberg GD; Bales GT; Brendler CB
    J Urol; 1998 May; 159(5):1431-6. PubMed ID: 9554328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expectant management of prostate cancer.
    Griffin AS; O'Rourke ME
    Semin Oncol Nurs; 2001 May; 17(2):101-7. PubMed ID: 11383241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.